Feedback / Questions
Xolremdi (mavorixafor) - X4 Pharma, Norgine
https://www.globenewswire.com/news-release/2025/06/16/3099765/0/en/X4-Pharmaceuticals-Presents-Positive-Phase-2-Chronic-Neutropenia-Trial-Data-in-Poster-Presentations-at-the-30th-Annual-Congress-of-the-European-Hematology-Association-EHA.html
Jun 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next